TTM
21.8%
YoY change
+3.01pp
Trough year (2001)
9.9%
Peak year (2010)
26.2%
Latest annual
17.9%
FCF Margin history chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025
Latest: 17.9%
FCF Margin change chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025
Latest: +3.01pp
FCF Margin history table for Zimmer Biomet Holdings (ZBH) from 1998 to 2025
| 2025 | 17.9% | +3.01pp | ||
| 2024 | 14.9% | -1.17pp | ||
| 2023 | 16.1% | +0.68pp | ||
| 2022 | 15.4% | -4.36pp | ||
| 2021 | 19.7% | +1.90pp | ||
| 2020 | 17.8% | +3.03pp | ||
| 2019 | 14.8% | -5.18pp | ||
| 2018 | 20.0% | +1.70pp | ||
| 2017 | 18.3% | -0.60pp | ||
| 2016 | 18.9% | +7.50pp | ||
| 2015 | 11.4% | -8.22pp | ||
| 2014 | 19.6% | +0.92pp | ||
| 2013 | 18.7% | -4.53pp | ||
| 2012 | 23.2% | -0.69pp | ||
| 2011 | 23.9% | -2.32pp | ||
| 2010 | 26.2% | +5.38pp | ||
| 2009 | 20.8% | +10.13pp | ||
| 2008 | 10.7% | -8.63pp | ||
| 2007 | 19.3% | -2.77pp | ||
| 2006 | 22.1% | -1.42pp | ||
| 2005 | 23.5% | -2.02pp | ||
| 2004 | 25.5% | +7.85pp | ||
| 2003 | 17.7% | +4.10pp | ||
| 2002 | 13.6% | +3.65pp | ||
| 2001 | 9.9% | -9.61pp | ||
| 2000 | 19.5% | +3.89pp | ||
| 1999 | 15.7% | -5.13pp | ||
| 1998 | 20.8% | — |
- 202517.9%+3.01pp
- 202414.9%-1.17pp
- 202316.1%+0.68pp
- 202215.4%-4.36pp
- 202119.7%+1.90pp
- 202017.8%+3.03pp
- 201914.8%-5.18pp
- 201820.0%+1.70pp
- 201718.3%-0.60pp
- 201618.9%+7.50pp
- 201511.4%-8.22pp
- 201419.6%+0.92pp
- 201318.7%-4.53pp
- 201223.2%-0.69pp
- 201123.9%-2.32pp
- 201026.2%+5.38pp
- 200920.8%+10.13pp
- 200810.7%-8.63pp
- 200719.3%-2.77pp
- 200622.1%-1.42pp
- 200523.5%-2.02pp
- 200425.5%+7.85pp
- 200317.7%+4.10pp
- 200213.6%+3.65pp
- 20019.9%-9.61pp
- 200019.5%+3.89pp
- 199915.7%-5.13pp
- 199820.8%—
FCF Margin values are taken from Zimmer Biomet Holdings's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Zimmer Biomet Holdings (ZBH)
According to Zimmer Biomet Holdings's latest reported financial statements, the company's latest reported free cash flow margin is 21.8%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Zimmer Biomet Holdings (ZBH) free cash flow margin totalled 17.89% – expanded 3.0 percentage points year-over-year.
Across the available history, free cash flow margin reached its high of 26.20% in 2010 and its low of 9.94% in 2001.
Zimmer Biomet Holdings FCF Margin by Year
Zimmer Biomet Holdings FCF Margin 2025: 17.9%
2025's free cash flow margin for Zimmer Biomet Holdings came in at 17.89%, expanded 3.0 percentage points from 2024.
Zimmer Biomet Holdings FCF Margin 2024: 14.9%
Zimmer Biomet Holdings posted free cash flow margin of 14.88% in 2024, contracted 1.2 percentage points from 2023.
Zimmer Biomet Holdings FCF Margin 2023: 16.1%
In 2023, Zimmer Biomet Holdings reported free cash flow margin of 16.05%, expanded 0.7 percentage points from 2022.
Zimmer Biomet Holdings FCF Margin 2022: 15.4%
Zimmer Biomet Holdings free cash flow margin in 2022 was 15.38%, contracted 4.4 percentage points from 2021.
Zimmer Biomet Holdings FCF Margin 2021: 19.7%
Zimmer Biomet Holdings free cash flow margin in 2021 was 19.73%.
See more financial history for Zimmer Biomet Holdings (ZBH).
Sector peers by FCF Margin
Healthcare peers of Zimmer Biomet Holdings (ZBH), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Zimmer Biomet Holdings (ZBH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation